Bone health in postmenopausal women

Overview

Bone health in postmenopausal women refers to the decreased bone density and increased fracture risk that occurs after menopause due to declining estrogen levels. This condition, often leading to osteoporosis, causes bones to become weak, brittle, and more susceptible to breaks from minor falls or everyday activities.

Common Causes

During menopause, declining estrogen levels significantly reduce the body's ability to maintain bone density, as estrogen plays a crucial role in bone formation and calcium absorption. The natural aging process also slows down bone regeneration, making bones more fragile over time. Lifestyle factors such as lack of weight-bearing exercise, insufficient calcium and vitamin D intake, smoking, and excessive alcohol consumption can further accelerate bone loss during this stage of life.

Severity Levels

Mild: You may notice occasional joint stiffness or minor aches, particularly in the morning or after periods of inactivity. Bone density tests might show early signs of bone loss, but fractures are uncommon at this stage.

Moderate: You may experience more frequent bone or joint discomfort and notice you're not as steady on your feet as before. Minor falls or bumps might result in unexpected fractures, and you may feel less confident about physical activities.

Severe: Fractures can occur from very minor incidents like coughing, bending over, or light bumping into objects. Daily activities become challenging due to fear of breaking bones, and you may experience significant limitations in mobility and independence.

Medical Attention

Consult your doctor if you experience frequent fractures from minor falls, persistent back pain, or notice you're getting shorter or developing a hunched posture. Schedule regular bone density screenings as recommended by your healthcare provider, especially if you have risk factors like family history or long-term medication use. Seek immediate medical attention if you suffer a fall and suspect a fracture, particularly in the hip, spine, or wrist areas.

4k+ Collection Centres

90k+ Biomarkers Tested

Early Detection